Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Isabel Rauscher; Wolfgang P. Fendler; Thomas A. Hope; Andrew Quon; Stephan G. Nekolla; Jeremie Calais; Antonia Richter; Bernhard Haller; Ken Herrmann; Wolfgang A. Weber; Johannes Czernin; Matthias Eiber

doi:10.2967/jnumed.119.227207

Research ArticleOncology

Can the Injected Dose Be Reduced in ⁶⁸Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Isabel Rauscher, Wolfgang P. Fendler, Thomas A. Hope, Andrew Quon, Stephan G. Nekolla, Jeremie Calais, Antonia Richter, Bernhard Haller, Ken Herrmann, Wolfgang A. Weber, Johannes Czernin and Matthias Eiber

Journal of Nuclear Medicine February 2020, 61 (2) 189-193; DOI: https://doi.org/10.2967/jnumed.119.227207

Isabel Rauscher

1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang P. Fendler

2Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas A. Hope

4Department of Radiology and Biomedical Imaging, University of California, San Francisco, California; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew Quon

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephan G. Nekolla

1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremie Calais

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Antonia Richter

1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernhard Haller

5Institute of Medical Informatics, Statistics and Epidemiology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

2Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang A. Weber

1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

3Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 2

February 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Can the Injected Dose Be Reduced in ⁶⁸Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Journal of Nuclear Medicine Feb 2020, 61 (2) 189-193; DOI: 10.2967/jnumed.119.227207

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Can the Injected Dose Be Reduced in ⁶⁸Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Journal of Nuclear Medicine Feb 2020, 61 (2) 189-193; DOI: 10.2967/jnumed.119.227207

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Lesion Detection and Administered Activity

Google Scholar

Oncology

18F-FDG PET/CT manifestations of three Cases of Female Desmoplastic Small Round Cell Tumor
18F-FDG PET/CT imaging features of parotid lesions; Case based pictorial review and its multi-modality correlation.
Utility of Fluorine-18-fluorodeoxyglucose PET/CT in Uterine sarcoma patients.

Show more Oncology

Clinical

SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Detection of Early Progression with ¹⁸F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

Show more Clinical

Keywords

Image dose
dose reduction
PSMA
prostate cancer

Main menu

User menu

Search

Can the Injected Dose Be Reduced in ⁶⁸Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Clinical

Similar Articles

Keywords